Patient group funding
European Organisation for Rare Diseases (Eurordis)
Eurordis is a patient-driven alliance of patient organisations and individuals active in the field of rare diseases.
Eurordis’ mission is to build a strong pan-European community of patient organisations and people living with rare diseases, to be their voice at the European level, and - directly or indirectly - to fight against the impact of rare diseases on their lives.
We have supported this organisation since 2006.
During 2010:
- We gave an unrestricted grant of €10000 to become a member of the round table of companies. This was created to establish a long-term educational relationship between Eurordis and companies that have an interest in orphan drug development.
- We gave an educational grant of €5000 to help support the organisation of the 5th European Conference on Rare Diseases ECRD in Krakow, Poland.
Our funding represents around 0.42% of their income overall.
During 2009:
- We gave an unrestricted grant of €10000 to become a member of the round table of companies. This was created to establish a long-term educational relationship between Eurordis and companies that have an interest in orphan drug development.
- Also we gave an educational grant of €5000 to support the organisation of Eurordis Membership meeting on 8 and 9 May in Athens.
During 2008:
- We gave an unrestricted grant €10,000 to become a member of the round table of companies. This was created to establish a long-term educational relationship between Eurordis and companies that have an interest in orphan drug development.
- In addition we gave an educational grant of €5000 to help support the Eurordis annual membership meeting held in Copenhagen in May.
During 2007:
- We gave an unrestricted grant of €10,000 to become a member of the round table of companies. This was created to establish a long-term educational relationship between Eurordis and companies that have an interest in orphan drug development.
- In addition we gave an educational grant of €1000 to help support the Eurordis annual membership meeting.
Our funding represents around 0.4% of their income overall.
In 2006:
- We gave an unrestricted grant of €10,000 to become a member of the round table of companies. This was created to establish a long-term educational relationship between Euordis and companies that have an interest in orphan drug development.
Our funding represents less than 1% of their income overall.